{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:52:04Z","timestamp":1790790724056,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,14]]},"DOI":"10.7759\/cureus.78989","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T12:26:46Z","timestamp":1739536006000},"source":"Crossref","is-referenced-by-count":1,"title":["The Critical Importance of Diagnosing Atypical Hemolytic Uremic Syndrome in Postpartum Renal Dysfunction in a Patient With Systemic Lupus Erythematosus: A Case Report and Comprehensive Review"],"prefix":"10.7759","author":[{"given":"Ayako","family":"Inatomi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Tokoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Katsura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Sawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli L","year":"2017","unstructured":"Andreoli L, Bertsias GK, Agmon-Levin N, et al.. EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome. Ann Rheum Dis. 2017, 76:476-85. 10.1136\/annrheumdis-2016-209770","journal-title":"Ann Rheum Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(24)00160-7","article-title":"Pregnancy outcome predictors in systemic lupus erythematosus: a systematic review and meta-analysis","volume":"6","author":"Wind M","year":"2024","unstructured":"Wind M, Fierro JJ, Bloemenkamp KW, et al.. Pregnancy outcome predictors in systemic lupus erythematosus: a systematic review and meta-analysis. Lancet Rheumatol. 2024, 6:667-83. 10.1016\/S2665-9913(24)00160-7","journal-title":"Lancet Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.05.014","article-title":"Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome","volume":"96","author":"Cavero T","year":"2019","unstructured":"Cavero T, Arjona E, Soto K, et al.. Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome. Kidney Int. 2019, 96:995-1004. 10.1016\/j.kint.2019.05.014","journal-title":"Kidney Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2012.195","article-title":"STEC-HUS, atypical HUS and TTP are all diseases of complement activation","volume":"8","author":"Noris M","year":"2012","unstructured":"Noris M, Mescia F, Remuzzi G. STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat Rev Nephrol. 2012, 8:622-33. 10.1038\/nrneph.2012.195","journal-title":"Nat Rev Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.03.055","article-title":"Expert statements on the standard of care in critically ill adult patients with atypical hemolytic uremic syndrome","volume":"152","author":"Azoulay E","year":"2017","unstructured":"Azoulay E, Knoebl P, Garnacho-Montero J, et al.. Expert statements on the standard of care in critically ill adult patients with atypical hemolytic uremic syndrome. Chest. 2017, 152:424-34. 10.1016\/j.chest.2017.03.055","journal-title":"Chest"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(93)90043-i","article-title":"Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)","volume":"169","author":"Sibai BM","year":"1993","unstructured":"Sibai BM, Ramadan MK, Usta I, et al.. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obst Gynecol. 1993, 169:1000-6. 10.1016\/0002-9378(93)90043-i","journal-title":"Am J Obst Gynecol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009070706","article-title":"Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations","volume":"21","author":"Fakhouri F","year":"2010","unstructured":"Fakhouri F, Roumenina L, Provot F, et al.. Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations. J Am Soc Nephrol. 2010, 21:859-67. 10.1681\/ASN.2009070706","journal-title":"J Am Soc Nephrol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.31138\/mjr.28.1.4","article-title":"Flares in systemic lupus erythematosus: diagnosis, risk factors and preventive strategies","volume":"28","author":"Adamichou C","year":"2017","unstructured":"Adamichou C, Bertsias G. Flares in systemic lupus erythematosus: diagnosis, risk factors and preventive strategies. Mediterr J Rheumatol. 2017, 28:4-12. 10.31138\/mjr.28.1.4","journal-title":"Mediterr J Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13947","article-title":"Thrombocytopenia in high-risk patients with antiphospholipid syndrome","volume":"16","author":"Pontara E","year":"2018","unstructured":"Pontara E, Banzato A, Bison E, et al.. Thrombocytopenia in high-risk patients with antiphospholipid syndrome. J Thromb Haemost. 2018, 16:529-32. 10.1111\/jth.13947","journal-title":"J Thromb Haemost"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004100861","article-title":"Hemolytic uremic syndrome","volume":"16","author":"Noris M","year":"2005","unstructured":"Noris M, Remuzzi G. Hemolytic uremic syndrome. J Am Soc Nephrol. 2005, 16:1035-50. 10.1681\/ASN.2004100861","journal-title":"J Am Soc Nephrol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-061813-013241","article-title":"ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura","volume":"66","author":"Zheng XL","year":"2015","unstructured":"Zheng XL. ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura. Annu Rev Med. 2015, 66:211-25. 10.1146\/annurev-med-061813-013241","journal-title":"Annu Rev Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2015.07.005","article-title":"An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document","volume":"35","author":"Campistol JM","year":"2015","unstructured":"Campistol JM, Arias M, Ariceta G, et al.. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document. Nefrologia. 2015, 35:421-47. 10.1016\/j.nefro.2015.07.005","journal-title":"Nefrologia"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1376153","article-title":"Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches","volume":"40","author":"Riedl M","year":"2014","unstructured":"Riedl M, Fakhouri F, Le Quintrec M, Noone DG, Jungraithmayr TC, Fremeaux-Bacchi V, Licht C. Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches. Semin Thromb Hemost. 2014, 40:444-64. 10.1055\/s-0034-1376153","journal-title":"Semin Thromb Hemost"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016090995","article-title":"Maternal and fetal outcomes of pregnancies in women with atypical hemolytic uremic syndrome","volume":"29","author":"Gaggl M","year":"2018","unstructured":"Gaggl M, Aigner C, Csuka D, et al.. Maternal and fetal outcomes of pregnancies in women with atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2018, 29:1020-9. 10.1681\/ASN.2016090995","journal-title":"J Am Soc Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.02.326","article-title":"Soluble c5b-9 as a biomarker for complement activation in atypical hemolytic uremic syndrome","volume":"65","author":"Bu F","year":"2015","unstructured":"Bu F, Meyer NC, Zhang Y, Borsa NG, Thomas C, Nester C, Smith RJ. Soluble c5b-9 as a biomarker for complement activation in atypical hemolytic uremic syndrome. Am J Kidney Dis. 2015, 65:968-9. 10.1053\/j.ajkd.2015.02.326","journal-title":"Am J Kidney Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/341901-the-critical-importance-of-diagnosing-atypical-hemolytic-uremic-syndrome-in-postpartum-renal-dysfunction-in-a-patient-with-systemic-lupus-erythematosus-a-case-report-and-comprehensive-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T12:26:48Z","timestamp":1739536008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/341901-the-critical-importance-of-diagnosing-atypical-hemolytic-uremic-syndrome-in-postpartum-renal-dysfunction-in-a-patient-with-systemic-lupus-erythematosus-a-case-report-and-comprehensive-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.78989","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,14]]}}}